The global proteomics market size is expected to reach USD 97.7 billion by 2033, registering a CAGR of 13.3% from 2026 to 2033, according to a new report by Grand View Research, Inc. The major factors driving theindustry growth are a rise in the demand for personalized medicine, an expansion of the pipeline of diagnostics utilizing proteomics mass spectrometry as well as biochip platforms, and discoveries based on genomics. Moreover, owing to the importance of proteomics in drug development, numerous pharmaceutical companies have established their own proteomic divisions, which are fueling the expansion of the global industry. For instance, in September 2021, Biognosys, announced the collaboration with Evotec, to promote the use of next-generation proteomics in clinical research and drug discovery.
The COVID-19 outbreak is expected to have a significant impact on the industry, as researchers across the world are concentrating on decoding 3D structures of SARS-CoV-2 proteins. To create effective medications and biological products against COVID-19, scientists are also attempting to examine the identification techniques, structures, characterization, and interactions of these proteins. The protein structure of virus proteins and their specific locations must be understood to find a novel, efficient target treatment medication for a virus. Therefore, it will increase the demand for drug development for COVID-19 and propel industry growth. The growing need for customized medications increased R&D spending, and technological developments related to proteomics components are also driving the market.
In addition, attractive market expansion potential for proteomics is anticipated to come from improvements in mass spectrometry-based proteomics and lucrative opportunities related to biomarker identification. Thereby, propelling the market growth.The introduction of new and improved proteomics techniques by major industry participants is projected to further accelerate the growth of the industry. For instance, to provide quick data acquisition for shotgun proteomics, Bruker Corp. introduced the timsTOF Pro system for Parallel Accumulation And Serial Fragmentation (PASEF) mass spectrometry in September 2017. This system uses proprietary Trapped Ion Mobility Spectrometry (TIMS) technology.Furthermore, proteomic research advancements have accelerated the detection of protein biomarkers, protein biochips & pharmacoproteomics, and proteomics-based molecular diagnostics, which have all made significant contributions to the development of personalized medicine.
Request a free sample copy or view report summary: Proteomics Market Report
Chronic diseases, such as cardiovascular conditions, diabetes, and cancer, account for a substantial portion of global morbidity and mortality.
The proteomics industry is experiencing a significant degree of innovation driven by technological advancements in mass spectrometry and next-generation sequencing technology.
The reagents & consumables segment accounted for the largest revenue share of 70.9% in 2025. Kits designed for mass spectrometry enable researchers to identify proteins within complex biological samples accurately.
The spectrometry segment captured the largest revenue share of 74.6% in 2025. It is also expected to expand further at the highest during the forecast period.
The drug discovery segment is expected to experience the fastest growth rate during the forecast period from 2026 to 2033, driven by increasing investments in pharmaceutical and biotechnology R&D, rising demand for targeted therapeutics, and the growing adoption of precision medicine.
Grand View Research has segmented the global proteomics market based on product & service, application, technology, and region:
Proteomics Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
Instruments
Reagents & Consumables
Services
Proteomics Application Outlook (Revenue, USD Million, 2021 - 2033)
Clinical Diagnostics
Drug Discovery
Others
Proteomics Technology Outlook (Revenue, USD Million, 2021 - 2033)
Microarray Instruments
X-Ray Crystallography
Spectrometry
Chromatography
Protein Fractionation Systems
Electrophoresis
Surface Plasma Resonance (SPR) Systems
Proteomics Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List Of Key Players Proteomics Market
Illumina, Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific, Inc.
Bruker Corporation
F. Hoffmann-La Roche Ltd.
Waters Corporation
Merck KGaA
Danaher
Standard BioTools Inc.
Seer, Inc
QIAGEN
"The quality of research they have done for us has been excellent..."